Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
Evaluate whether the effect of inhaled tiotropium bromide on the change in trough forced
expiratory volume (FEV1), compared to placebo in patients with chronic obstructive pulmonary
disease (COPD), is affected by smoking status.